Glatiramer Subcutaneous and Xultophy
Determining the interaction of Glatiramer Subcutaneous and Xultophy and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glatiramer
Brand name: Copaxone, Glatopa
Synonyms: Glatiramer (injection), Glatiramer Acetate
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Xultophy 100/3.6
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glatiramer Subcutaneous-Xultophy 100/3.6
- Glatiramer Subcutaneous-Xuriden
- Glatiramer Subcutaneous-Xylocaine
- Glatiramer Subcutaneous-Xylocaine (Cardiac)
- Glatiramer Subcutaneous-Xylocaine (Lidocaine Injection Solution (Anesthetic))
- Glatiramer Subcutaneous-Xylocaine (Lidocaine Oral Liquid and Solution)
- Xultophy-Glatopa
- Xultophy-Glatopa injection
- Xultophy-Glecaprevir and pibrentasvir
- Xultophy-Gleevec
- Xultophy-Glenmax PEB DM
- Xultophy-Glenmax PEB DM FORTE